INTERPLAY OF COMPLEMENT AND CYTOKINES IN THE PATHOGENESIS OF SEPTIC SHOCK

被引:46
作者
DEBOER, JP
WOLBINK, GJ
THIJS, LG
BAARS, JW
WAGSTAFF, J
HACK, CE
机构
[1] NETHERLANDS RED CROSS, BLOOD TRANSFUS SERV, CENT LAB, POB 9406, 1006 AK AMSTERDAM, NETHERLANDS
[2] UNIV AMSTERDAM, EXPTL & CLIN IMMUNOL LAB, AMSTERDAM, NETHERLANDS
[3] FREE UNIV AMSTERDAM HOSP, MED INTENS CARE UNIT, AMSTERDAM, NETHERLANDS
[4] FREE UNIV AMSTERDAM HOSP, DEPT ONCOL, AMSTERDAM, NETHERLANDS
来源
IMMUNOPHARMACOLOGY | 1992年 / 24卷 / 02期
关键词
COMPLEMENT; CYTOKINE; SEPSIS;
D O I
10.1016/0162-3109(92)90019-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sepsis is a clinical syndrome that is usually induced by bacterial infections. It is generally assumed that the syndrome results from an excessive triggering of endogenous inflammatory mediators by the invading microorganisms. These mediators include substances released by activated monocytes, macrophages, endothelial cells and neutrophils such as cytokines, reactive oxygen species and proteases, as well as activation products of coagulation, fibrinolysis, contact and complement systems. Recent studies have suggested that cytokines and complement activation products may have overlapping biological activities. In addition, multiple interactions in vitro as well as in vivo between cytokines and complement have been described. Here we will review some of these recent studies and will discuss their relevance for the pathogenesis of sepsis and septic shock.
引用
收藏
页码:135 / 148
页数:14
相关论文
共 161 条
  • [91] Muller-Eberhard H.J., 1988, INFLAMMATION BASIC P, P21
  • [92] MUNRO JM, 1991, LAB INVEST, V64, P295
  • [93] ENDOTOXIN AND TUMOR NECROSIS FACTOR CHALLENGES IN DOGS SIMULATE THE CARDIOVASCULAR PROFILE OF HUMAN SEPTIC SHOCK
    NATANSON, C
    EICHENHOLZ, PW
    DANNER, RL
    EICHACKER, PQ
    HOFFMAN, WD
    KUO, GC
    BANKS, SM
    MACVITTIE, TJ
    PARRILLO, JE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (03) : 823 - 832
  • [94] MODULATION OF ENDOTHELIAL-CELL HEMOSTATIC PROPERTIES BY TUMOR-NECROSIS-FACTOR
    NAWROTH, PP
    STERN, DM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (03) : 740 - 745
  • [95] NUIJENS JH, 1992, J LAB CLIN MED, V119, P159
  • [96] INTERLEUKIN-2 ADMINISTRATION CAUSES REVERSIBLE HEMODYNAMIC-CHANGES AND LEFT-VENTRICULAR DYSFUNCTION SIMILAR TO THOSE SEEN IN SEPTIC SHOCK
    OGNIBENE, FP
    ROSENBERG, SA
    LOTZE, M
    SKIBBER, J
    PARKER, MM
    SHELHAMER, JH
    PARRILLO, JE
    [J]. CHEST, 1988, 94 (04) : 750 - 754
  • [97] INTERLEUKIN-1 RECEPTOR ANTAGONIST REDUCES MORTALITY FROM ENDOTOXIN-SHOCK
    OHLSSON, K
    BJORK, P
    BERGENFELDT, M
    HAGEMAN, R
    THOMPSON, RC
    [J]. NATURE, 1990, 348 (6301) : 550 - 552
  • [98] OKUSAWA S, 1987, J IMMUNOL, V139, P2635
  • [99] C5A STIMULATES SECRETION OF TUMOR NECROSIS FACTOR FROM HUMAN MONONUCLEAR-CELLS INVITRO - COMPARISON WITH SECRETION OF INTERLEUKIN-1-BETA AND INTERLEUKIN-1-ALPHA
    OKUSAWA, S
    YANCEY, KB
    VANDERMEER, JWM
    ENDRES, S
    LONNEMANN, G
    HEFTER, K
    FRANK, MM
    BURKE, JF
    DINARELLO, CA
    GELFAND, JA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (01) : 443 - 448
  • [100] INTERLEUKIN-1 INDUCES A SHOCK-LIKE STATE IN RABBITS - SYNERGISM WITH TUMOR NECROSIS FACTOR AND THE EFFECT OF CYCLOOXYGENASE INHIBITION
    OKUSAWA, S
    GELFAND, JA
    IKEJIMA, T
    CONNOLLY, RJ
    DINARELLO, CA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (04) : 1162 - 1172